Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.
An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.
Scotland's researchers and doctors have performed a non-invasive operation on a patient with Parkinson’s disease using the country’s first ultrasound thalamotomy that allowed.